Cycloartenol acetate

Details

Top
Internal ID 6140b924-5683-49a4-a103-c683f7542754
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Cycloartanols and derivatives
IUPAC Name [(1S,3R,6S,8R,11S,12S,15R,16R)-7,7,12,16-tetramethyl-15-[(2R)-6-methylhept-5-en-2-yl]-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] acetate
SMILES (Canonical) CC(CCC=C(C)C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)OC(=O)C)C)C
SMILES (Isomeric) C[C@H](CCC=C(C)C)[C@H]1CC[C@@]2([C@@]1(CC[C@]34[C@H]2CC[C@@H]5[C@]3(C4)CC[C@@H](C5(C)C)OC(=O)C)C)C
InChI InChI=1S/C32H52O2/c1-21(2)10-9-11-22(3)24-14-16-30(8)26-13-12-25-28(5,6)27(34-23(4)33)15-17-31(25)20-32(26,31)19-18-29(24,30)7/h10,22,24-27H,9,11-20H2,1-8H3/t22-,24-,25+,26+,27+,29-,30+,31-,32+/m1/s1
InChI Key PQNTWKDHNSWVPU-OSWLCJEWSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C32H52O2
Molecular Weight 468.80 g/mol
Exact Mass 468.396730897 g/mol
Topological Polar Surface Area (TPSA) 26.30 Ų
XlogP 10.30
Atomic LogP (AlogP) 8.74
H-Bond Acceptor 2
H-Bond Donor 0
Rotatable Bonds 5

Synonyms

Top
1259-10-5
CHEMBL226035
SCHEMBL13420441
AKOS040763766

2D Structure

Top
2D Structure of Cycloartenol acetate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 1.0000 100.00%
Caco-2 - 0.5942 59.42%
Blood Brain Barrier + 0.8000 80.00%
Human oral bioavailability - 0.5286 52.86%
Subcellular localzation Mitochondria 0.6504 65.04%
OATP2B1 inhibitior - 0.7162 71.62%
OATP1B1 inhibitior + 0.7201 72.01%
OATP1B3 inhibitior - 0.3112 31.12%
MATE1 inhibitior - 0.8800 88.00%
OCT2 inhibitior - 0.6750 67.50%
BSEP inhibitior + 0.9507 95.07%
P-glycoprotein inhibitior + 0.6069 60.69%
P-glycoprotein substrate - 0.7502 75.02%
CYP3A4 substrate + 0.6599 65.99%
CYP2C9 substrate - 0.8000 80.00%
CYP2D6 substrate - 0.8527 85.27%
CYP3A4 inhibition - 0.8696 86.96%
CYP2C9 inhibition - 0.8171 81.71%
CYP2C19 inhibition + 0.6064 60.64%
CYP2D6 inhibition - 0.9467 94.67%
CYP1A2 inhibition - 0.8558 85.58%
CYP2C8 inhibition - 0.7209 72.09%
CYP inhibitory promiscuity - 0.6464 64.64%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9600 96.00%
Carcinogenicity (trinary) Non-required 0.5402 54.02%
Eye corrosion - 0.9891 98.91%
Eye irritation - 0.9165 91.65%
Skin irritation - 0.5112 51.12%
Skin corrosion - 0.9785 97.85%
Ames mutagenesis - 0.7728 77.28%
Human Ether-a-go-go-Related Gene inhibition + 0.8267 82.67%
Micronuclear - 0.7300 73.00%
Hepatotoxicity - 0.7002 70.02%
skin sensitisation + 0.6024 60.24%
Respiratory toxicity + 0.5111 51.11%
Reproductive toxicity + 0.8000 80.00%
Mitochondrial toxicity + 0.6375 63.75%
Nephrotoxicity - 0.6133 61.33%
Acute Oral Toxicity (c) III 0.7749 77.49%
Estrogen receptor binding + 0.8304 83.04%
Androgen receptor binding + 0.7658 76.58%
Thyroid receptor binding + 0.5893 58.93%
Glucocorticoid receptor binding + 0.8023 80.23%
Aromatase binding + 0.8151 81.51%
PPAR gamma + 0.7058 70.58%
Honey bee toxicity - 0.7193 71.93%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity - 0.6655 66.55%
Fish aquatic toxicity + 0.9969 99.69%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 97.29% 94.45%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.50% 96.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 94.89% 97.25%
CHEMBL2581 P07339 Cathepsin D 92.96% 98.95%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 92.96% 91.11%
CHEMBL340 P08684 Cytochrome P450 3A4 89.96% 91.19%
CHEMBL3145 P42338 PI3-kinase p110-beta subunit 88.54% 98.75%
CHEMBL2413 P32246 C-C chemokine receptor type 1 86.17% 89.50%
CHEMBL3807 P17706 T-cell protein-tyrosine phosphatase 85.72% 93.00%
CHEMBL3746 P80365 11-beta-hydroxysteroid dehydrogenase 2 85.14% 94.78%
CHEMBL3359 P21462 Formyl peptide receptor 1 84.94% 93.56%
CHEMBL3837 P07711 Cathepsin L 84.77% 96.61%
CHEMBL4005 P42336 PI3-kinase p110-alpha subunit 84.48% 97.47%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 84.43% 100.00%
CHEMBL4227 P25090 Lipoxin A4 receptor 84.40% 100.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 84.07% 97.09%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 83.83% 92.62%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 83.78% 95.50%
CHEMBL5608 Q16288 NT-3 growth factor receptor 83.24% 95.89%
CHEMBL1907602 P06493 Cyclin-dependent kinase 1/cyclin B1 83.02% 91.24%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 81.79% 82.69%
CHEMBL1293316 Q9HBX9 Relaxin receptor 1 81.76% 82.50%
CHEMBL1994 P08235 Mineralocorticoid receptor 81.43% 100.00%
CHEMBL6136 O60341 Lysine-specific histone demethylase 1 81.21% 95.58%
CHEMBL1937 Q92769 Histone deacetylase 2 80.62% 94.75%
CHEMBL4051 P13569 Cystic fibrosis transmembrane conductance regulator 80.54% 95.71%
CHEMBL3430907 Q96GD4 Aurora kinase B/Inner centromere protein 80.53% 97.50%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 80.44% 94.33%

Cross-Links

Top
PubChem 13023741
NPASS NPC139206
ChEMBL CHEMBL226035
LOTUS LTS0217131
wikiData Q104250608